☰

Norca M. Dowling, Ph.D. - Publications

Affiliations: 
2006 University of Wisconsin, Madison, Madison, WI 
Area:
Psychometrics Psychology
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Dowling NM, Bolt DM, Deng S. An Approach for Estimating Item Sensitivity to Within-Person Change Over Time: An Illustration Using the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog). Psychological Assessment. PMID 27046272 DOI: 10.1037/pas0000285  0.357
2015 Gleason CE, Dowling NM, Benton SF, Kaseroff A, Gunn W, Edwards DF. Common Sense Model Factors Affecting African Americans' Willingness to Consult a Healthcare Provider Regarding Symptoms of Mild Cognitive Impairment. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. PMID 26809602 DOI: 10.1016/j.jagp.2015.08.005  0.322
2015 Gleason CE, Fischer BL, Dowling NM, Setchell KD, Atwood CS, Carlsson CM, Asthana S. Cognitive Effects of Soy Isoflavones in Patients with Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 47: 1009-19. PMID 26401779 DOI: 10.3233/JAD-142958  0.363
2015 Doherty BM, Schultz SA, Oh JM, Koscik RL, Dowling NM, Barnhart TE, Murali D, Gallagher CL, Carlsson CM, Bendlin BB, LaRue A, Hermann BP, Rowley HA, Asthana S, Sager MA, et al. Amyloid burden, cortical thickness, and cognitive function in the Wisconsin Registry for Alzheimer's Prevention. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring. 1: 160-169. PMID 26161436 DOI: 10.1016/j.dadm.2015.01.003  0.424
2015 Gleason CE, Dowling NM, Wharton W, Manson JE, Miller VM, Atwood CS, Brinton EA, Cedars MI, Lobo RA, Merriam GR, Neal-Perry G, Santoro NF, Taylor HS, Black DM, Budoff MJ, et al. Effects of Hormone Therapy on Cognition and Mood in Recently Postmenopausal Women: Findings from the Randomized, Controlled KEEPS-Cognitive and Affective Study. Plos Medicine. 12: e1001833. PMID 26035291 DOI: 10.1371/Journal.Pmed.1001833  0.302
2015 Schultz SA, Oh JM, Koscik RL, Dowling NM, Gallagher CL, Carlsson CM, Bendlin BB, LaRue A, Hermann BP, Rowley HA, Asthana S, Sager MA, Johnson SC, Okonkwo OC. Subjective memory complaints, cortical thinning, and cognitive dysfunction in middle-aged adults at risk for AD. Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring. 1: 33-40. PMID 25938132 DOI: 10.1016/J.Dadm.2014.11.010  0.327
2015 Almeida RP, Schultz SA, Austin BP, Boots EA, Dowling NM, Gleason CE, Bendlin BB, Sager MA, Hermann BP, Zetterberg H, Carlsson CM, Johnson SC, Asthana S, Okonkwo OC. Effect of Cognitive Reserve on Age-Related Changes in Cerebrospinal Fluid Biomarkers of Alzheimer Disease. Jama Neurology. 72: 699-706. PMID 25893879 DOI: 10.1001/Jamaneurol.2015.0098  0.391
2015 Li C, Dowling NM, Chappell R. Quantile regression with a change-point model for longitudinal data: An application to the study of cognitive changes in preclinical alzheimer's disease. Biometrics. PMID 25892034 DOI: 10.1111/Biom.12313  0.403
2015 Dowling NM, Johnson SC, Gleason CE, Jagust WJ. The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. Neuroimage. 105: 357-68. PMID 25450107 DOI: 10.1016/j.neuroimage.2014.10.050  0.364
2015 Gleason CE, Fischer BL, Dowling NM, Setchell KDR, Atwood CS, Carlsson CM, Asthana S. Cognitive effects of soy isoflavones in patients with Alzheimer's disease Journal of Alzheimer's Disease. 47: 1009-1019. DOI: 10.3233/JAD-142958  0.375
2014 Okonkwo OC, Schultz SA, Oh JM, Larson J, Edwards D, Cook D, Koscik R, Gallagher CL, Dowling NM, Carlsson CM, Bendlin BB, LaRue A, Rowley HA, Christian BT, Asthana S, et al. Physical activity attenuates age-related biomarker alterations in preclinical AD. Neurology. 83: 1753-60. PMID 25298312 DOI: 10.1212/Wnl.0000000000000964  0.406
2014 Racine AM, Adluru N, Alexander AL, Christian BT, Okonkwo OC, Oh J, Cleary CA, Birdsill A, Hillmer AT, Murali D, Barnhart TE, Gallagher CL, Carlsson CM, Rowley HA, Dowling NM, et al. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation. Neuroimage. Clinical. 4: 604-14. PMID 24936411 DOI: 10.1016/J.Nicl.2014.02.001  0.339
2014 Okonkwo OC, Oh JM, Koscik R, Jonaitis E, Cleary CA, Dowling NM, Bendlin BB, Larue A, Hermann BP, Barnhart TE, Murali D, Rowley HA, Carlsson CM, Gallagher CL, Asthana S, et al. Amyloid burden, neuronal function, and cognitive decline in middle-aged adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 20: 422-33. PMID 24621494 DOI: 10.1017/S1355617714000113  0.398
2014 Wharton W, Gleason CE, Dowling NM, Carlsson CM, Brinton EA, Santoro MN, Neal-Perry G, Taylor H, Naftolin F, Lobo RA, Merriam G, Manson JE, Cedars MI, Miller VM, Black DM, et al. The KEEPS-Cognitive and Affective Study: baseline associations between vascular risk factors and cognition. Journal of Alzheimer's Disease : Jad. 40: 331-41. PMID 24430001 DOI: 10.3233/Jad-130245  0.428
2014 Johnson SC, Christian BT, Okonkwo OC, Oh JM, Harding S, Xu G, Hillmer AT, Wooten DW, Murali D, Barnhart TE, Hall LT, Racine AM, Klunk WE, Mathis CA, Bendlin BB, ... ... Dowling NM, et al. Amyloid burden and neural function in people at risk for Alzheimer's Disease. Neurobiology of Aging. 35: 576-84. PMID 24269021 DOI: 10.1016/J.Neurobiolaging.2013.09.028  0.415
2014 Okonkwo OC, Xu G, Oh JM, Dowling NM, Carlsson CM, Gallagher CL, Birdsill AC, Palotti M, Wharton W, Hermann BP, LaRue A, Bendlin BB, Rowley HA, Asthana S, Sager MA, et al. Cerebral blood flow is diminished in asymptomatic middle-aged adults with maternal history of Alzheimer's disease. Cerebral Cortex (New York, N.Y. : 1991). 24: 978-88. PMID 23236200 DOI: 10.1093/Cercor/Bhs381  0.351
2014 Dowling NM, Bolt D. A Procedure For Identifying Items Capturing Cognitive Change Across Time: An Illustration Using The Alzheimer'S Disease Assessment Scale-Cognitive (Adas-Cog) Alzheimers & Dementia. 10: 565. DOI: 10.1016/J.Jalz.2014.05.920  0.321
2014 Dowling NM, Bolt DM, Gleason CE. A Comparison Of Novel Approaches For Examining Differential Item Functioning In The Montreal Cognitive Assessment: A Multiple Covariate Approach Alzheimers & Dementia. 10: 725. DOI: 10.1016/J.Jalz.2014.05.1346  0.344
2014 Dowling N, Johnson S, Zetterberg H, Bendlin BB, Gleason CE, Carlsson C, Sager MA. P3-100: HETEROGENEITY OF CEREBROSPINAL FLUID BIOMARKER LEVELS IN COGNITIVELY NORMAL INDIVIDUALS WITH A FAMILY HISTORY OF ALZHEIMER'S DISEASE Alzheimer's & Dementia. 10: P664-P664. DOI: 10.1016/J.Jalz.2014.05.1188  0.323
2013 Dowling NM, Gleason CE, Manson JE, Hodis HN, Miller VM, Brinton EA, Neal-Perry G, Santoro MN, Cedars M, Lobo R, Merriam GR, Wharton W, Naftolin F, Taylor H, Harman SM, et al. Characterization of vascular disease risk in postmenopausal women and its association with cognitive performance. Plos One. 8: e68741. PMID 23874743 DOI: 10.1371/Journal.Pone.0068741  0.335
2012 Okonkwo OC, Xu G, Dowling NM, Bendlin BB, Larue A, Hermann BP, Koscik R, Jonaitis E, Rowley HA, Carlsson CM, Asthana S, Sager MA, Johnson SC. Family history of Alzheimer disease predicts hippocampal atrophy in healthy middle-aged adults. Neurology. 78: 1769-76. PMID 22592366 DOI: 10.1212/Wnl.0B013E3182583047  0.46
2011 Dowling NM, Tomaszewski Farias S, Reed BR, Sonnen JA, Strauss ME, Schneider JA, Bennett DA, Mungas D. Neuropathological associates of multiple cognitive functions in two community-based cohorts of older adults. Journal of the International Neuropsychological Society : Jins. 17: 602-14. PMID 21092373 DOI: 10.1017/S1355617710001426  0.367
2010 Dowling NM, Hermann B, La Rue A, Sager MA. Latent Structure and Factorial Invariance of a Neuropsychological Test Battery for the Study of Preclinical Alzheimer's Disease Neuropsychology. 24: 742-756. PMID 21038965 DOI: 10.1037/A0020176  0.318
2010 Lin F, Wharton W, Dowling NM, Ries ML, Johnson SC, Carlsson CM, Asthana S, Gleason CE. Awareness of memory abilities in community-dwelling older adults with suspected dementia and mild cognitive impairment. Dementia and Geriatric Cognitive Disorders. 30: 83-92. PMID 20714155 DOI: 10.1159/000318752  0.306
2010 Jacobson LE, Gleason CE, Hermann BP, Johnson SC, Barnet JH, Blazel HM, Dowling NM, Sager MA, Asthana S, Carlsson CM. P1-008: Gender differences in cognitive performance and response to simvastatin in adults at risk for Alzheimer's disease: (The ESPRIT Study) Alzheimer's & Dementia. 6: S176-S176. DOI: 10.1016/J.Jalz.2010.05.555  0.438
2009 Gleason CE, Wharton WL, Dowling NM, Rowley J, LaRue A, Hermann BP, Asthana S, Sager MA. Hormone therapy use and risk factors for Alzheimer's disease: Data from the Wisconsin Registry for Alzheimer's Prevention Alzheimers & Dementia. 5: 333. DOI: 10.1016/J.Jalz.2009.04.562  0.341
2008 Gleason CE, Dowling NM, Wharton W, Khosropour CM, Carlsson CM, Asthana S. P2-393: Cognitive benefits of hormone therapy use in women matched for cardiovascular risk factors Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1471  0.356
Show low-probability matches.